Healthpeak Properties (NYSE:DOC) Reaches New 52-Week High Following Analyst Upgrade

Healthpeak Properties, Inc. (NYSE:DOC) shares reached a new 52-week high on Thursday after Wells Fargo & Company raised their price target on the stock from $20.00 to $22.00. Wells Fargo & Company currently has an equal weight rating on the stock. Healthpeak Properties traded as high as $22.13 and last traded at $22.1050, with a volume of 342183 shares. The stock had previously closed at $21.74.

Other equities analysts have also recently issued reports about the stock. JPMorgan Chase & Co. boosted their target price on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. Barclays began coverage on shares of Healthpeak Properties in a research report on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 price target on the stock. UBS Group lifted their price objective on shares of Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Royal Bank Of Canada boosted their price objective on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. Finally, Scotiabank upped their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 27th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $20.62.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.23% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently made changes to their positions in DOC. Advocate Investing Services LLC acquired a new stake in Healthpeak Properties in the fourth quarter valued at approximately $26,000. WPG Advisers LLC grew its stake in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties during the second quarter worth $33,000. Clearstead Advisors LLC increased its holdings in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after buying an additional 1,216 shares in the last quarter. Finally, Elyxium Wealth LLC acquired a new position in shares of Healthpeak Properties during the fourth quarter worth $31,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Up 0.9%

The company has a market capitalization of $15.53 billion, a P/E ratio of 70.39, a PEG ratio of 3.47 and a beta of 1.02. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a 50 day moving average price of $20.47 and a 200 day moving average price of $18.24.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.Healthpeak Properties’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.